Back to Journals » Biologics: Targets and Therapy » Volume 13

Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy

Total article views   Abstract views HTML views PDF downloads Totals
14,331 Dovepress* 4,710 2,174+ 1,912 6,884
PubMed Central* 0 7,447 1,301 7,447
Totals 4,710 9,621 3,213 14,331
*Since 21 December 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar